News Industry News Jardiance® demonstrated cardiovascular (CV) risk reduction in people with type 2 diabetes at high risk for CV events August 20, 2015
News Industry News Micell Technologies Announces First Patient Enrolled in Registration Trial of MiStent SES in China July 22, 2015